Cargando…
Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions
We previously established that COX-2 overexpression promotes breast cancer progression and metastasis. As long-term use of COX-2 inhibitors (COX-2i) can promote thrombo-embolic events, we tested an alternative target, prostaglandin E2 receptor EP4 subtype (EP4), downstream of COX-2. Here we used the...
Autores principales: | Majumder, Mousumi, Xin, Xiping, Liu, Ling, Girish, Gannareddy V, Lala, Peeyush K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462388/ https://www.ncbi.nlm.nih.gov/pubmed/24981602 http://dx.doi.org/10.1111/cas.12475 |
Ejemplares similares
-
PGE2 promotes breast cancer-associated lymphangiogenesis by activation of EP4 receptor on lymphatic endothelial cells
por: Nandi, Pinki, et al.
Publicado: (2017) -
Prostaglandin E2 Receptor 4 (EP4) as a Therapeutic Target to Impede Breast Cancer-Associated Angiogenesis and Lymphangiogenesis
por: De Paz Linares, Guillermo Antonio, et al.
Publicado: (2021) -
The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis
por: Tutunea-Fatan, Elena, et al.
Publicado: (2015) -
EP4 as a Therapeutic Target for Aggressive Human Breast Cancer
por: Majumder, Mousumi, et al.
Publicado: (2018) -
Signaling of Prostaglandin E Receptors, EP3 and EP4 Facilitates Wound Healing and Lymphangiogenesis with Enhanced Recruitment of M2 Macrophages in Mice
por: Hosono, Kanako, et al.
Publicado: (2016)